Thioredoxin reductase 1 mRNA 3' untranslated region (TXNRD1 mRNA 3'UTR)

The Thioredoxin Reductase 1 (TXNRD1) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the messenger RNA encoding the TXNRD1 enzyme, which is essential for maintaining cellular redox balance (UniProt P36969). This region is uniquely characterized by the presence of a Selenocysteine Insertion Sequence (SECIS) element, which directs the translational machinery to incorporate selenocysteine at the UGA codon rather than terminating translation (PubMed: 10574773). In many pathological states, particularly cancer, TXNRD1 is overexpressed to protect cells from oxidative stress and facilitate rapid growth, making its mRNA a high-priority therapeutic target (PubMed: 29153511). Therapeutic interventions targeting the 3'UTR, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), aim to induce mRNA degradation or block translation, thereby depleting the cell's antioxidant defenses (PubMed: 25666443). Furthermore, the 3'UTR contains multiple binding sites for microRNAs like miR-125b, which serve as endogenous regulators of TXNRD1 expression and are being explored for their tumor-suppressive potential (PubMed: 23603115). By disrupting the stability or translation of TXNRD1 mRNA through its 3'UTR, researchers hope to sensitize resistant cancer cells to pro-oxidant therapies and induce apoptosis. This target represents a sophisticated approach to modulating the thioredoxin system at the post-transcriptional level.

Other names

TXNRD1 3'UTRThioredoxin reductase 1 3' untranslated regionTR1 mRNA 3'UTRTXNRD1 SECIS element

Antisense-mediated mRNA degradation, RNA interference (RNAi), or inhibition of selenocysteine insertion via SECIS element disruption.